Page last updated: 2024-12-10

prostaglandin i3

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5283049
CHEBI ID165339
MeSH IDM0105663

Synonyms (11)

Synonym
LMFA03010045
6,9s-epoxy-11r,15s-dihydroxy-15z,13e,17z-prostatrienoic acid
prostaglandin i3
pgi3
68794-57-0
(5z)-5-[(3ar,4r,5r,6as)-5-hydroxy-4-[(1e,3s,5z)-3-hydroxyocta-1,5-dienyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]uran-2-ylidene]pentanoic acid
CHEBI:165339
prosta-5,13,17-trien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5z,9alpha,11alpha,13e,15s,17z)-
prostaglandin i3 (sodium salt)
NCYSTSFUYSFMEO-OBLTVXDOSA-N
6,9.alpha.-epoxy-11.alpha.,15s-dihydroxy-prosta-5z,13e,17z-trien-1-oic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
prostanoidThe family of natural prostaglandins and prostaglandin-like compounds including prostacyclins and thromboxanes.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (75.00)18.7374
1990's2 (10.00)18.2507
2000's2 (10.00)29.6817
2010's1 (5.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.93 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (8.70%)5.53%
Reviews2 (8.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (82.61%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]